Invention Grant
- Patent Title: Therapeutic agent for emphysema and COPD
- Patent Title (中): 肺气肿和COPD治疗剂
-
Application No.: US14004781Application Date: 2012-03-20
-
Publication No.: US09585930B2Publication Date: 2017-03-07
- Inventor: Avrum Spira , Marc Lenburg , Joshua Campbell , Dimitri Petchkovski , Darryl Andrew Knight , James Cameron Hogg , Julie Erin Zeskind Gil
- Applicant: Avrum Spira , Marc Lenburg , Joshua Campbell , Dimitri Petchkovski , Darryl Andrew Knight , James Cameron Hogg , Julie Erin Zeskind Gil
- Applicant Address: US MA Boston CA Vancouver
- Assignee: Trustees of Boston University,The University of British Columbia
- Current Assignee: Trustees of Boston University,The University of British Columbia
- Current Assignee Address: US MA Boston CA Vancouver
- Agency: Nixon Peabody LLP
- International Application: PCT/US2012/029823 WO 20120320
- International Announcement: WO2012/129237 WO 20120927
- Main IPC: A61K38/06
- IPC: A61K38/06 ; A61K38/07 ; A61M11/00 ; A61M15/00 ; A61M16/10 ; C12Q1/68 ; G01N33/53 ; G01N33/00 ; C40B30/04 ; G01N33/68 ; A61K9/00 ; A61K45/06 ; A61M16/14 ; G01N33/543 ; G01N33/569
Abstract:
The invention described herein relates to methods of treating emphysema and COPD with a GHK tripeptide. The invention further relates to methods of determining the state of the lungs using biomarkers described herein.
Public/Granted literature
- US20140199411A1 THERAPEUTIC AGENT FOR EMPHYSEMA AND COPD Public/Granted day:2014-07-17
Information query
IPC分类:
